Wang Zhenzhen,Liu Dichuan,Cai Min,Wu Jian.Allopurinol improves cardiac function of chronic heart failure rats[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(10):1021-1025.
Wang Zhenzhen,Liu Dichuan,Cai Min,Wu Jian.Allopurinol improves cardiac function of chronic heart failure rats[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(10):1021-1025.DOI:
Allopurinol improves cardiac function of chronic heart failure rats
Objective To determine the protective effect of allopurinol (ALLO) on cardiac function in rats with chronic heart failure and its antioxidant mechanism in improving cardiac function.
Methods Thirty-five of 6-weeks-old male SD rats average weighted (200±20)g
randomly divided into the ALLO treatment group (n=12)
control group (n=13) and sham-operated group (n=10).SD rats in ALLO treatment group and the control group were established of acute myocardial infarction (AMI) models by ligation of the left anterior descending coronary artery
and SD rats of sham-operated group underwent the same procedure
including anesthesia and open-chest surgery
but the artery was not ligated. Two days after the surgery
ALLO treatment group underwent gavage administration by ALLO(50 mg/kg·d)
while the gavage administration in control group and sham-operated group were only by the saline. Eight weeks later
the cardiac function of SD rats
levels of brain natriuretic peptide (BNP)
expression of xanthine oxidase(XO)
malondialdehyde (MDA)
the activity of mitochondrial complexⅠ-Ⅳ
morphological changes in myocardial tissue and the expression of iNOS were detected and analyzed. Results Compared with the rats in sham-operated group
rats in control group showed poor cardiac function(
P
0.05)
significantly increased expression of XO (
P
0.05)
increased BNP content and MDA level(
P
0.05)
significant decrease of the activity of mitochondrial complexⅠ
Ⅲ and Ⅳ(
P
0.05)
HE staining revealed obvious myocardial tissue edema and obviously increased iNOS expression (
P
0.05) in control group
which revealed that the CHF model had been set up successfully. While compared with control group
rats in ALLO treatment group showed better cardiac function(
P
0.05)
decreased XO expression (
P
0.05) and BNP content and MDA level (
P
0.05)
increased activity of mitochondrial complexⅠ
Ⅲ and Ⅳ(
P
0.05)
alleviated tissue loosening and edema (
P
0.05)
markedly inhibited iNOS expression (
P
0.05). Conclusion CHF model is set up successfully
and ALLO can improve chronic heart failure rats cardiac function. The mechanism maybe associated with